$100K in new capital is heading to Ananya Health, the medical device company developing a platform to freeze abnormal cells in the cervix before they become malignant cervical cancer. The funding comes from EHA Impact Ventures.
Ananya Health's cryoablation platform aims to generate standard of care outcomes without consumable cryogen gas, specifically designed to overcome barriers to cancer prevention.

















